Phase II Trial of Sorafenib in Patients With Metastatic Breast Cancer Previously Exposed to Anthracyclines or Taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0...

Por Moreno-Aspitia, Alvaro, Morton, Roscoe F., Hillman, David W., Lingle, Wilma L., Rowland, Kendrith M., Wiesenfeld, Martin, Flynn, Patrick J., Fitch, Tom R., Perez, Edith A.
Publicado em 2009

Phase II Interventional Study (N0337) of Capecitabine in Combination With Vinorelbine and Trastuzumab for First- or Second-Line Treatment of HER2-Positive Metastatic Breast Cancer:...

Por Tan, Winston W., Allred, Jacob B., Salim, Muhammad, Flynn, Patrick, Fishkin, Paul A. S., Stella, Philip J., Wiesenfeld, Martin, Bernath, Albert M., Fitch, Tom R., Perez, Edith A.
Publicado no Clin Breast Cancer (2012)

Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results

Por Santisteban, Marta, Buckner, Jan C., Reid, Joel M., Wu, Wenting, Scheithauer, Bernd W., Ames, Matthew M., Felten, Sara J., Nikcevich, Daniel A., Wiesenfeld, Martin, Jaeckle, Kurt A., Galanis, Evanthia
Publicado em 2008